DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines

被引：0
|
作者：
Risher, J. Devon [1 ,2 ]
Rivenbark, Ashley G. [1 ,2 ]
Jones, Wendell D. [3 ]
Coleman, William B. [1 ,2 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] Express Anal, Durham, NC USA
来源：
FASEB JOURNAL | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines
    J Devon Roll
    Ashley G Rivenbark
    Wendell D Jones
    William B Coleman
    Molecular Cancer, 7
  • [2] DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines
    Roll, J. Devon
    Rivenbark, Ashley G.
    Jones, Wendell D.
    Coleman, William B.
    MOLECULAR CANCER, 2008, 7 (1)
  • [3] RNAi-Mediated Knockdown of DNMT3b in Hypermethylator Breast Cancer Cell Lines Leads to Normalization of Gene Expression Patterns
    Roll, J. Devon
    Rinkenbaugh, Amanda L.
    Sandhu, Rupninder
    Rivenbark, Ashley G.
    Coleman, William B.
    FASEB JOURNAL, 2009, 23
  • [4] Sensitization of Hypermethylator Breast Cancer Cells to Chemotherapy by Targeted and Pharmacologic Inhibition of DNMT3b
    Sandhu, Rupninder
    Rivenbark, Ashley G.
    Coleman, William B.
    FASEB JOURNAL, 2011, 25
  • [5] Dysregulation of Multiple MicroRNAs Accompanies DNMT3b Overexpression and Expression of a Hypermethylation Defect in Breast Cancer Cell Lines
    Sandhu, Rupninder
    Coleman, William B.
    FASEB JOURNAL, 2010, 24
  • [6] Aberrant DNA methyltransferase 3b activity accounts for the hypermethylator phenotype in human breast cancer cell lines
    Risher, J. Devon
    Coleman, William B.
    FASEB JOURNAL, 2007, 21 (06): : A755 - A756
  • [7] Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b
    Sandhu, Rupninder
    Rivenbark, Ashley G.
    Coleman, William B.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) : 385 - 399
  • [8] Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b
    Rupninder Sandhu
    Ashley G. Rivenbark
    William B. Coleman
    Breast Cancer Research and Treatment, 2012, 131 : 385 - 399
  • [9] A novel DNMT3B subfamily, ΔDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer
    Wang, Luo
    Wang, Jie
    Sun, Shiyong
    Rodriguez, Marivonne
    Yue, Ping
    Jang, Se Jin
    Mao, Li
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (01) : 201 - 207
  • [10] Oncogenic BRAFV600e Downregulates DNMT3B and Does Not Directly Induce the CpG Island Hypermethylator Phenotype in Human Colorectal
    MacKenzie, Douglas J.
    Robertson, Neil A.
    Cole, John
    Adams, Peter
    GASTROENTEROLOGY, 2015, 148 (04) : S570 - S570
12345